Tigecycline use in serious nosocomial infections: A drug use evaluation

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Bassetti, Matteo ^a   Nicolini, Laura ^a   Repetto, Ernestina ^a   Righi, Elda ^a   Del Bono, Valerio ^a   Viscoli, Claudio ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; COLISTIN; MEROPENEM; TIGECYCLINE; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; MINOCYCLINE;

ABDOMINAL INFECTION; ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CRITICALLY ILL PATIENT; DIARRHEA; DRUG EFFICACY; DRUG USE; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NAUSEA AND VOMITING; NONHUMAN; PERITONITIS; PROSPECTIVE STUDY; SIDE EFFECT; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA; BACTERIAL INFECTION; BACTERIUM; CASE REPORT; CROSS INFECTION; DRUG EFFECT; MIDDLE AGED; PATHOLOGY; TIME; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CROSS INFECTION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; MINOCYCLINE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77957138110     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-287     Document Type: Article

References (15)

1. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007, 35(10 Suppl 2). S165YS193.
2. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med 2005, 165:1375-1380. 10.1001/archinte.165.12.1375, 15983286.
3. Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, Landman D. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in itro activity of polymyxin B and other agents. J Antimicrob Chemother 2005, 56:128-32. 10.1093/jac/dki175, 15917285.
4. Hawkey P, Finch R. Tigecycline: in-vitro performance as a predictorof clinical efficacy. Clin Microbiol Infect 2007, 13:354-62. 10.1111/j.1469-0691.2006.01621.x, 17359318.
5. Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E, . Tigecycline 301 Study Group; Tigecycline 306 Study Group The efficacy and safety of tigecycline for the treatment of complicated intraabdominal infections: analysis of pooled clinical trial data. Clin Infect Dis 2005, 41:S354-67. 10.1086/431676, 16080073, Tigecycline 301 Study Group; Tigecycline 306 Study Group.
6. Ellis-Grosse EJ, Babinchak T, Dartois N, Rose G, Loh E, . Tigecycline 300 cSSSI Study Group; Tigecycline 305 cSSSI Study Group The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam. Clin Infect Dis 2005, 41:S341-53. 10.1086/431675, 16080072, Tigecycline 300 cSSSI Study Group; Tigecycline 305 cSSSI Study Group.
7. Tanaseanu C, Milutinovic S, Calistru PI, Strausz J, Zolubas M, Chernyak V, Dartois N, Castaing N, Gandjini H, Cooper CA, . 313 Study Group Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia. BMC Pulm Med 2009, 9:44. 10.1186/1471-2466-9-44, 2753558, 19740418, 313 Study Group.
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-40. 10.1016/0196-6553(88)90053-3, 2841893.
9. Swoboda S, Ober M, Hainer C, Lichtenstern C, Seiler C, Wendt C, Hoppe-Tichy T, Büchler M, Weigand MA. Tigecycline for the treatment of patients with serious sepsis or septic shock: a drug use evaluation in a surgical intensive care unit. J Antimicrob Chemother 2008, 61:729-33. 10.1093/jac/dkm541, 18222953.
10. Chemaly RF, Hanmod SS, Jiang Y, Rathod DB, Mulanovich V, Adachi JA, Rolston KV, Raad II, Hachem RY. Tigecycline Use in Cancer Patients With Serious Infections A Report on 110 Cases From a Single Institution. Medicine 2009, 88:211-220. 10.1097/MD.0b013e3181af01fc, 19593226.
11. Poulakou G, Kontopidou FV, Paramythiotou E, Kompoti M, Katsiari M, Mainas E, Nicolaou C, Yphantis D, Antoniadou A, Trikka-Graphakos E, Roussou Z, Clouva P, Maguina N, Kanellakopoulou K, Armaganidis A, Giamarellou H. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens. J Infect 2009, 58:273-284. 10.1016/j.jinf.2009.02.009, 19344841.
12. Schafer JJ, Goff DA, Stevenson KB, Mangino JE. Early experience with tigecycline for ventilator-associated pneumonia and bacteraemia caused by multidrug-resistant Acinetobacter baumannii. Pharmacother 2007, 27:980-7.
13. Gallagher JC, Rouse HM. Tigecycline for the treatment of Acinetobacter infections: a case series. Ann Pharmacother 2008, 42:1188-94. 10.1345/aph.1L171, 18614749.
14. Karageorgopoulos DE, Kelesidis T, Kelesidis I, Falagas ME. Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother 2008, 62:45-55. 10.1093/jac/dkn165, 18436554.
15. Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM, . Infectious Diseases Society of America; Society for Healthcare Epidemiology of America Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44:159-77. 10.1086/510393, 17173212, Infectious Diseases Society of America; Society for Healthcare Epidemiology of America.